Servicios Personalizados
Revista
Articulo
Español (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Anestesia en México
versión On-line ISSN 2448-8771versión impresa ISSN 1405-0056
Resumen
CARRANZA CORTES, José Luis y BRITO MADRID, Adelina. Choque hemorrágico en fase II. Efecto del Hidroxi-etil-almidón al 10% sobre el gasto cardiaco. Anest. Méx. [online]. 2016, vol.28, n.2, pp.11-15. ISSN 2448-8771.
Maintenance of Cardiac Output (Qt), in patients with hemorrhagic shock in Phase II, is crucial to prevent multiple organ failure evolve in the immediate postoperative period.
Objective:
To determine if there is an increase in cardiac output in patients with hemorrhagic shock in Phase II, with the administration of Hydroxy ethyl 10% starch.
Material and Methods:
A prospective and longitudinal study of cases, in patients with hemorrhagic shock in phase II was performed. Patients were administered hydroxyethyl starch 10% at 15 mL/kg as a single dose and were evaluated in three stages, the variables of cardiac output and systemic oxygen by repeated measures ANOVA P <0.05.
Results:
A total of 20 patients (N = 20) were studied. An increase in Qt and the availability of oxygen (DO2), mainly in stages II and III of the study, no statistical impact was observed. The oxygen consumption (VO2), remained constant throughout the study. The oxygen extraction rate (O2ER), was observed in normal range and total peripheral resistance (TPR), they had a descent without significant evidence.
Discussion:
Qt, DO2, and systemic oxygenation were appropriate behavior. No oxygen debt data for the study. It is concluded that the hydroxyl-ethyl starch 10%, was useful and supports cardiac output in patients with hemorrhagic shock in Phase II.
Palabras llave : cardiac output; hydroxyethyl starch 10%; hemorrhagic shock.
